Search results

Page results

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• John McGrath

  John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.

• New national study on long-term health impacts of COVID-19 launched

  UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.

• Ward T16 North - Haematology

  T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.

• Contrast Extravasation (contrast leakage)

  Contrast Extravasation (contrast leakage) patient information leaflet

• Training programmes perform well in this year’s GMC National Training Survey

  We are pleased to have performed very well again in this year's General Medical Council National Training Survey.

• Peripherally inserted central catheters (PICCs)

  This information is for UCLH patients with cancer or a blood condition who are being offered a PICC (peripherally inserted central catheter).

• Loss of smell a ‘highly specific’ indicator of Covid-19, finds UCLH and UCL research

  Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.

• Age no criterion for decisions on heart attack treatment, new research finds

  Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.